title: Current management and prevention of malaria in pregnancy: a review.
abstract: BACKGROUND
  Pregnant women suffer more frequent and severe malaria than non-pregnant women. Malaria in pregnancy contributes to the high maternal and perinatal morbidity and mortality in Africa.
  
  
  OBJECTIVE
  To review the burden and highlight the current management and prevention strategies for control of malaria in pregnancy in Africa.
  
  
  METHODS
  Papers for this review were identified by searches of PubMed and Google, and references from relevant articles. Search terms were "malaria", "malaria in pregnancy", "Malaria during pregnancy" and "antimalarial drug". Only papers published in English between 1983 and 2013 were included.
  
  
  RESULTS
  In malarial endemic areas, acquired partial malarial immunity is not effective during pregnancy. Pregnant women are prone to frequent malaria infections which may be severe or asymptomatic but associated with placental parasitization. Malaria contributes 2-15% to maternal anaemia, 13-70% to intrauterine growth restriction, 8-14% to low birth weight, 8-36% to prematurity, 3-8% to infant deaths and 2.9-17.6% to maternal mortality. The control of malaria in pregnancy is currently predicated on three main strategies: 1) Prompt and effective case management of malaria; 2).Use of Insecticide-treated nets; and 3).Intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine. Artemisinin-based combined therapy is the recommended treatment for uncomplicated malaria in the second and third trimesters of pregnancy, while quinine is used in the first trimester and for severe cases of malaria at any gestational age.
  
  
  CONCLUSIONS
  The control of malaria during pregnancy should be an integral part of efforts to reduce maternal and perinatal morbidity and mortality in Africa.
authors.affiliation: Department of Obstetrics & Gynaecology, National Hospital, Abuja, Nigeria.
authors.forename: C O
authors.initials: CO
authors.lastname: Agboghoroma
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000962:Antimalarials / Q000627:therapeutic use*; D018890:Chemoprevention; D005260:Female; D015658:HIV Infections / Q000150:complications; D006801:Humans; D057148:Insecticide-Treated Bednets; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000517:prevention & control*
chemical_list: D000962:Antimalarials